This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.
We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.
Sensyne Health is a clinical artificial intelligence company operating a unique business model. We are a for-profit plc making a positive social impact, sharing the financial returns we make with the NHS via equity and a share of revenues.
We supply advanced patient monitoring software to healthcare providers that improve patient outcomes and reduce costs.
Software Products
We undertake research on behalf of pharmaceutical companies using clinical AI to analyse anonymised patient records to accelerate the development of new medicines.
Discovery Sciences
MagnifEye is an AI-powered software product that transforms any smartphone into an easy-to-use Lateral Flow Test (LFT) reader.
Find out more
Our response to COVID-19, building on our experience and knowledge of remote patient monitoring to help people monitor their own health and support members of the community most in need.
Our Strategic Research Agreements (SRAs) with NHS Trusts allow us access to globally unique, longitudinal anonymised patient datasets.
Strategic Research Agreements
© 2020 Sensyne Health plc. All rights reserved.
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives
